2023 Q1 Form 10-K Financial Statement
#000139047823000005 Filed on March 16, 2023
Income Statement
| Concept | 2023 Q1 | 2022 Q4 | 2022 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $1.000M |
| YoY Change | -100.0% | -86.84% | |
| Cost Of Revenue | $0.00 | $0.00 | $100.0K |
| YoY Change | -100.0% | -50.0% | |
| Gross Profit | $0.00 | $0.00 | $900.0K |
| YoY Change | -100.0% | -87.84% | |
| Gross Profit Margin | 90.0% | ||
| Selling, General & Admin | $4.107M | $3.600M | $12.58M |
| YoY Change | 35.81% | 42.52% | 11.15% |
| % of Gross Profit | 1398.0% | ||
| Research & Development | $7.174M | $5.846M | $20.27M |
| YoY Change | 55.58% | 72.3% | 29.31% |
| % of Gross Profit | 2252.0% | ||
| Depreciation & Amortization | |||
| YoY Change | |||
| % of Gross Profit | |||
| Operating Expenses | $11.28M | $9.446M | $32.85M |
| YoY Change | 47.75% | 59.59% | 21.69% |
| Operating Profit | -$11.28M | -$9.446M | -$41.95M |
| YoY Change | -32.59% | 59.59% | 65.85% |
| Interest Expense | $182.0K | $158.0K | $317.0K |
| YoY Change | 9000.0% | 5183.33% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | $2.000K | $167.0K | $649.0K |
| YoY Change | -118.18% | -96.51% | -85.11% |
| Pretax Income | -$11.10M | -$9.121M | -$41.30M |
| YoY Change | -33.73% | 33.45% | 97.27% |
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | |||
| Net Earnings | -$11.10M | -$9.121M | -$41.30M |
| YoY Change | -33.53% | 38.24% | 99.52% |
| Net Earnings / Revenue | -4130.0% | ||
| Basic Earnings Per Share | -$0.47 | -$2.13 | |
| Diluted Earnings Per Share | -$0.47 | -$0.44 | -$2.13 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 28.30M shares | 20.59M shares | 19.40M shares |
| Diluted Shares Outstanding | 23.55M shares | 19.40M shares |
Balance Sheet
| Concept | 2023 Q1 | 2022 Q4 | 2022 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $23.90M | $17.13M | $17.13M |
| YoY Change | 67.71% | -19.81% | -19.81% |
| Cash & Equivalents | $23.90M | $17.13M | $17.13M |
| Short-Term Investments | |||
| Other Short-Term Assets | $2.120M | $631.0K | $631.0K |
| YoY Change | -18.05% | -62.64% | -62.64% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $26.02M | $17.76M | $17.76M |
| YoY Change | 45.87% | -22.95% | -22.95% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $784.0K | $874.0K | $874.0K |
| YoY Change | -30.43% | 20.89% | 20.89% |
| Goodwill | $1.914M | $1.900M | |
| YoY Change | 0.0% | -0.73% | |
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $384.0K | $399.0K | $399.0K |
| YoY Change | -30.69% | -32.83% | -32.83% |
| Total Long-Term Assets | $3.082M | $3.187M | $3.187M |
| YoY Change | -14.27% | -1.36% | -1.36% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $26.02M | $17.76M | $17.76M |
| Total Long-Term Assets | $3.082M | $3.187M | $3.187M |
| Total Assets | $29.10M | $20.94M | $20.94M |
| YoY Change | 35.78% | -20.29% | -20.29% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.099M | $3.357M | $3.357M |
| YoY Change | 9.04% | 56.58% | 56.58% |
| Accrued Expenses | $6.485M | $6.286M | $6.658M |
| YoY Change | 115.31% | 138.11% | 148.71% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $15.51M | $15.52M | $15.52M |
| YoY Change | 45.25% | 211.42% | 211.42% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $424.0K | $577.0K | $577.0K |
| YoY Change | -93.7% | -39.01% | -39.01% |
| Total Long-Term Liabilities | $424.0K | $577.0K | $577.0K |
| YoY Change | -93.7% | -39.01% | -39.01% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $15.51M | $15.52M | $15.52M |
| Total Long-Term Liabilities | $424.0K | $577.0K | $577.0K |
| Total Liabilities | $15.94M | $16.09M | $16.09M |
| YoY Change | -8.47% | 171.46% | 171.46% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$191.0M | -$179.9M | |
| YoY Change | 22.99% | 29.8% | |
| Common Stock | $204.2M | $184.8M | |
| YoY Change | 28.11% | 16.23% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $13.17M | $4.851M | $4.851M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $29.10M | $20.94M | $20.94M |
| YoY Change | 35.78% | -20.29% | -20.29% |
Cashflow Statement
| Concept | 2023 Q1 | 2022 Q4 | 2022 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$11.10M | -$9.121M | -$41.30M |
| YoY Change | -33.53% | 38.24% | 99.52% |
| Depreciation, Depletion And Amortization | |||
| YoY Change | |||
| Cash From Operating Activities | -$12.10M | -$5.152M | -$23.80M |
| YoY Change | 68.06% | 3.54% | -8.46% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | $4.500M | |
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | $0.00 | -$4.500M | |
| YoY Change | |||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $1.048M | ||
| YoY Change | -88.36% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | $18.90M | 929.0K | $24.08M |
| YoY Change | 40121.28% | 1758.0% | 99.43% |
| NET CHANGE | |||
| Cash From Operating Activities | -$12.10M | -5.152M | -$23.80M |
| Cash From Investing Activities | 0.000 | -$4.500M | |
| Cash From Financing Activities | $18.90M | 929.0K | $24.08M |
| Net Change In Cash | $6.777M | -4.223M | -$4.230M |
| YoY Change | -195.41% | -14.27% | -69.67% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$12.10M | -$5.152M | -$23.80M |
| Capital Expenditures | $0.00 | $4.500M | |
| Free Cash Flow | -$5.152M | -$28.30M | |
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2022Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
399000 | usd |
| CY2022Q4 | us-gaap |
Assets
Assets
|
20943000 | usd |
| CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3357000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
874000 | usd |
| CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
1914000 | usd |
| CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001390478 | |
| CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
| CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
45790691 | usd |
| CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
28302504 | shares |
| CY2022 | dei |
Auditor Firm
AuditorFirmId
|
659 | |
| CY2022 | dei |
Auditor Name
AuditorName
|
Moss Adams LLP | |
| CY2022 | dei |
Auditor Location
AuditorLocation
|
Campbell, California | |
| CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17125000 | usd |
| CY2022Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
100000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
531000 | usd |
| CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
17756000 | usd |
| CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6286000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
372000 | usd |
| CY2022Q4 | sls |
Acquired In Process Research And Development Payable Current
AcquiredInProcessResearchAndDevelopmentPayableCurrent
|
5500000 | usd |
| CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
15515000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
573000 | usd |
| CY2022Q4 | sls |
Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
|
4000 | usd |
| CY2021Q4 | sls |
Fair Value Of Warrants Potentially Settleable In Cash
FairValueOfWarrantsPotentiallySettleableInCash
|
40000 | usd |
| CY2022Q4 | sls |
Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
|
0 | usd |
| CY2021Q4 | sls |
Contingent Purchase Price Consideration Net Of Current Portion
ContingentPurchasePriceConsiderationNetOfCurrentPortion
|
296000 | usd |
| CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
5928000 | usd |
| CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
| CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
| CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
21005405 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
15895637 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
15895637 | shares |
| CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2000 | usd |
| CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
158948000 | usd |
| CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-138603000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20347000 | usd |
| CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
26275000 | usd |
| CY2021 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7600000 | usd |
| CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
200000 | usd |
| CY2021 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
15674000 | usd |
| CY2021 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
11320000 | usd |
| CY2022 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
10000000 | usd |
| CY2021 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
0 | usd |
| CY2022 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
0 | usd |
| CY2021 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
5700000 | usd |
| CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-36000 | usd |
| CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-15000 | usd |
| CY2022 | sls |
Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
|
296000 | usd |
| CY2021 | sls |
Change In Fair Value Of Contingent Purchase Price Consideration
ChangeInFairValueOfContingentPurchasePriceConsideration
|
4337000 | usd |
| CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
317000 | usd |
| CY2021 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
6000 | usd |
| CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
649000 | usd |
| CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4358000 | usd |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-41301000 | usd |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-20936000 | usd |
| CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-237000 | usd |
| CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41301000 | usd |
| CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.13 | |
| CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.13 | |
| CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.34 | |
| CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.34 | |
| CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
19395709 | shares |
| CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
19395709 | shares |
| CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
15481113 | shares |
| CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
15481113 | shares |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27961000 | usd |
| CY2021 | sls |
Stock Issued During Period Value Common Stockand Warrants
StockIssuedDuringPeriodValueCommonStockandWarrants
|
9005000 | usd |
| CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3069000 | usd |
| CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1011000 | usd |
| CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20699000 | usd |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
20347000 | usd |
| CY2022 | sls |
Stock Issued During Period Value Common Stockand Warrants
StockIssuedDuringPeriodValueCommonStockandWarrants
|
22946000 | usd |
| CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1048000 | usd |
| CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1726000 | usd |
| CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1726000 | usd |
| CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41301000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4851000 | usd |
| CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41301000 | usd |
| CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-20699000 | usd |
| CY2022 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
10000000 | usd |
| CY2021 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
0 | usd |
| CY2022 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
0 | usd |
| CY2021 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
5700000 | usd |
| CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1726000 | usd |
| CY2022 | sls |
Non Cash Lease Expense
NonCashLeaseExpense
|
457000 | usd |
| CY2021 | sls |
Non Cash Lease Expense
NonCashLeaseExpense
|
173000 | usd |
| CY2022 | sls |
Change In Fair Value Of Contingent Purchase Consideration
ChangeInFairValueOfContingentPurchaseConsideration
|
296000 | usd |
| CY2022 | sls |
Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings
ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings
|
36000 | usd |
| CY2022 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
0 | usd |
| CY2021 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-239000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
0 | usd |
| CY2021 | us-gaap |
Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
|
-1128000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1253000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1174000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1213000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2513000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
3646000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
727000 | usd |
| CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-471000 | usd |
| CY2021 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-183000 | usd |
| CY2022 | sls |
Increase Decrease In Contract With Customer Liability Net
IncreaseDecreaseInContractWithCustomerLiabilityNet
|
0 | usd |
| CY2021 | sls |
Increase Decrease In Contract With Customer Liability Net
IncreaseDecreaseInContractWithCustomerLiabilityNet
|
-5600000 | usd |
| CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-23809000 | usd |
| CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-26021000 | usd |
| CY2022 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
4500000 | usd |
| CY2021 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
0 | usd |
| CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4500000 | usd |
| CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
| CY2022 | sls |
Proceeds From Issuance Of Common Stock And Common Stock Warrants
ProceedsFromIssuanceOfCommonStockAndCommonStockWarrants
|
22946000 | usd |
| CY2021 | sls |
Proceeds From Issuance Of Common Stock And Common Stock Warrants
ProceedsFromIssuanceOfCommonStockAndCommonStockWarrants
|
0 | usd |
| CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1048000 | usd |
| CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9005000 | usd |
| CY2022 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
85000 | usd |
| CY2021 | us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
0 | usd |
| CY2022 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | usd |
| CY2021 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
3069000 | usd |
| CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
24079000 | usd |
| CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12074000 | usd |
| CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4230000 | usd |
| CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-13947000 | usd |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
35402000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17225000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
21455000 | usd |
| CY2022 | us-gaap |
Proceeds From Interest Received
ProceedsFromInterestReceived
|
317000 | usd |
| CY2021 | us-gaap |
Proceeds From Interest Received
ProceedsFromInterestReceived
|
6000 | usd |
| CY2022Q4 | sls |
Acquired In Process Research And Development Payable
AcquiredInProcessResearchAndDevelopmentPayable
|
5500000 | usd |
| CY2021Q4 | sls |
Acquired In Process Research And Development Payable
AcquiredInProcessResearchAndDevelopmentPayable
|
0 | usd |
| CY2022 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
449000 | usd |
| CY2021 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
| CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-179900000 | usd |
| CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41300000 | usd |
| CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-23800000 | usd |
| CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17100000 | usd |
| CY2022 | sls |
Proceeds From Research And Development Arrangement Milestone Payments
ProceedsFromResearchAndDevelopmentArrangementMilestonePayments
|
13000000 | usd |
| CY2022 | sls |
Collaborative Arrangement Upfront Fee And Milestone Payments
CollaborativeArrangementUpfrontFeeAndMilestonePayments
|
10500000 | usd |
| CY2022 | sls |
Proceeds From Research And Development Arrangement Milestone Payments
ProceedsFromResearchAndDevelopmentArrangementMilestonePayments
|
13000000 | usd |
| CY2022 | sls |
Research And Development Arrangement Potential Milestone Payments To Be Received
ResearchAndDevelopmentArrangementPotentialMilestonePaymentsToBeReceived
|
191500000 | usd |
| CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, the Company evaluates its estimates using historical experience and other factors, including the current economic environment. Significant items subject to such estimates are assumptions used for purposes of determining stock-based compensation, carrying value of goodwill, accounting for deferred income taxes, and accounting for research and development activities. Management believes its estimates to be reasonable under the circumstances. Actual results could differ significantly from those estimates.</span></div> | |
| CY2022 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
| CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Credit Risk</span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with financial institutions, the balances of which frequently exceed federally insured limits. On March 10, 2023, Silicon Valley Bank ("SVB") was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation ("FDIC") as receiver.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the financial institutions with whom we do business were to be placed into receivership, we may be unable to access to the cash we have on deposit with such institutions.</span></div> | |
| CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17125000 | usd |
| CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
21355000 | usd |
| CY2022Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
100000 | usd |
| CY2021Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
100000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17225000 | usd |
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
21455000 | usd |
| CY2021 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
| CY2022 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
| CY2022 | sls |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Other Comprehensive Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleListNotDisclosedFlag
|
consolidated statements of operations | |
| CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
100000 | usd |
| CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
200000 | usd |
| CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
| CY2021Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | usd |
| CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6436000 | shares |
| CY2021 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1253000 | shares |
| CY2020Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
5700000 | usd |
| CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
1914000 | usd |
| CY2021 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
5700000 | usd |
| CY2021 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
| CY2021Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
0 | usd |
| CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
1914000 | usd |
| CY2022 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
0 | usd |
| CY2022 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
| CY2022Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
0 | usd |
| CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
1914000 | usd |
| CY2021Q4 | us-gaap |
Goodwill
Goodwill
|
1900000 | usd |
| CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
1900000 | usd |
| CY2021Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | usd |
| CY2022Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
0 | usd |
| CY2021 | us-gaap |
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
|
5700000 | usd |
| CY2021Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill Fair Value Disclosure
IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure
|
0 | usd |
| CY2022Q4 | sls |
Prepaid Research And Development
PrepaidResearchAndDevelopment
|
184000 | usd |
| CY2021Q4 | sls |
Prepaid Research And Development
PrepaidResearchAndDevelopment
|
1309000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
219000 | usd |
| CY2021Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
217000 | usd |
| CY2022Q4 | sls |
Prepaid Professional Services
PrepaidProfessionalServices
|
82000 | usd |
| CY2021Q4 | sls |
Prepaid Professional Services
PrepaidProfessionalServices
|
36000 | usd |
| CY2022Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
46000 | usd |
| CY2021Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
27000 | usd |
| CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
531000 | usd |
| CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1589000 | usd |
| CY2022Q4 | sls |
Contract Research Payable
ContractResearchPayable
|
4509000 | usd |
| CY2021Q4 | sls |
Contract Research Payable
ContractResearchPayable
|
1325000 | usd |
| CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1439000 | usd |
| CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
989000 | usd |
| CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
338000 | usd |
| CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
165000 | usd |
| CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
0 | usd |
| CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
161000 | usd |
| CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6286000 | usd |
| CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2640000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.1395 | |
| CY2022 | sls |
Operating Lease Remaining Lease Term
OperatingLeaseRemainingLeaseTerm
|
P2Y | |
| CY2022 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
500000 | usd |
| CY2021 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
300000 | usd |
| CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
500000 | usd |
| CY2021 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
300000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
518000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
533000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1051000 | usd |
| CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
106000 | usd |
| CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
945000 | usd |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
350000000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
5141000 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1040000 | shares |
| CY2022Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
7352000 | shares |
| CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1726000 | usd |
| CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1011000 | usd |
| CY2021Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
519000 | shares |
| CY2022 | sls |
Class Of Warrant Or Right Grants
ClassOfWarrantOrRightGrants
|
4630000 | shares |
| CY2022 | sls |
Classof Warrantor Right Canceled Or Expired
ClassofWarrantorRightCanceledOrExpired
|
8000 | shares |
| CY2022Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
5141000 | shares |
| CY2020Q4 | sls |
Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
|
55000 | usd |
| CY2021 | sls |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
-15000 | usd |
| CY2021Q4 | sls |
Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
|
40000 | usd |
| CY2022 | sls |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
-36000 | usd |
| CY2022Q4 | sls |
Fair Value Of Warrants Liabilities
FairValueOfWarrantsLiabilities
|
4000 | usd |
| CY2020Q4 | sls |
Research And Development Arrangement Cash Payment Received
ResearchAndDevelopmentArrangementCashPaymentReceived
|
7500000 | usd |
| CY2020Q4 | sls |
Research And Development Arrangement Potential Milestone Payments To Be Received Maximum
ResearchAndDevelopmentArrangementPotentialMilestonePaymentsToBeReceivedMaximum
|
194500000 | usd |
| CY2022Q4 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
9500000 | usd |
| CY2022 | sls |
Research And Development Arrangement Cash Payment Received
ResearchAndDevelopmentArrangementCashPaymentReceived
|
7500000 | usd |
| CY2022 | sls |
Research And Development Arrangement Milestones Probable Of Being Achieved
ResearchAndDevelopmentArrangementMilestonesProbableOfBeingAchieved
|
2000000 | usd |
| CY2021 | sls |
Contract With Customer Liability New Contract Revenue Recognized
ContractWithCustomerLiabilityNewContractRevenueRecognized
|
7600000 | usd |
| CY2021 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
9500000 | usd |
| CY2021 | sls |
Research And Development Arrangement Potential Milestone Payments To Be Received
ResearchAndDevelopmentArrangementPotentialMilestonePaymentsToBeReceived
|
192500000 | usd |
| CY2022Q2 | sls |
Proceeds From Research And Development Arrangement Milestone Payments
ProceedsFromResearchAndDevelopmentArrangementMilestonePayments
|
1000000 | usd |
| CY2022Q4 | sls |
Research And Development Arrangement Potential Milestone Payments To Be Received
ResearchAndDevelopmentArrangementPotentialMilestonePaymentsToBeReceived
|
191500000 | usd |
| CY2022Q4 | us-gaap |
Capitalized Contract Cost Gross
CapitalizedContractCostGross
|
1400000 | usd |
| CY2021 | us-gaap |
Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
|
1100000 | usd |
| CY2022 | us-gaap |
Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
|
0 | usd |
| CY2022 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
100000 | usd |
| CY2021 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
200000 | usd |
| CY2021Q4 | sls |
Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
|
3236000 | usd |
| CY2022Q4 | sls |
Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
|
0 | usd |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0196 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0105 | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.3151 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.2153 | |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y2M4D | |
| CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y2M4D | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
4.52 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
6.98 | |
| CY2022 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P10Y | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
2900000 | usd |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
208000 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
13.38 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
326000 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
8.00 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
534000 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
10.09 | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
546000 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.01 | |
| CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
40000 | shares |
| CY2022 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
6.17 | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1040000 | shares |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
7.57 | |
| CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y5M23D | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
91000 | usd |
| CY2022Q4 | sls |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableNumber
|
313000 | shares |
| CY2022Q4 | sls |
Sharebased Compensation Arrangementby Sharebased Payment Award Options Vested And Exercisable Weighted Average Exercise Price
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedAndExercisableWeightedAverageExercisePrice
|
12.38 | |
| CY2022 | sls |
Sharebased Compensation Arrangementby Sharebased Payment Award Options Vested And Exercisable Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedAndExercisableWeightedAverageRemainingContractualTerm
|
P7Y7M17D | |
| CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
66000 | usd |
| CY2022Q4 | sls |
Closing Price Of Common Stock
ClosingPriceOfCommonStock
|
2.36 | |
| CY2021Q4 | sls |
Deferred Tax Assets Contingent Consideration
DeferredTaxAssetsContingentConsideration
|
62000 | usd |
| CY2022Q4 | sls |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
198000 | usd |
| CY2021Q4 | sls |
Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
|
170000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
765000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
0 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
|
282000 | usd |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-17825000 | usd |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-6956000 | usd |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-23476000 | usd |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-13980000 | usd |
| CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-41301000 | usd |
| CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-20936000 | usd |
| CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | usd |
| CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2000 | usd |
| CY2022 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
0 | usd |
| CY2022 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
2000 | usd |
| CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-239000 | usd |
| CY2022 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
0 | usd |
| CY2022 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
|
0 | usd |
| CY2022 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-239000 | usd |
| CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-237000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
10529000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
9059000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
229000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
140000 | usd |
| CY2022Q4 | sls |
Deferred Tax Assets Licensing Deduction Deferral
DeferredTaxAssetsLicensingDeductionDeferral
|
4503000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
|
217000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
16506000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
12884000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
16322000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
12732000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
184000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
152000 | usd |
| CY2022Q4 | sls |
Deferred Tax Liability Right Of Use Asset
DeferredTaxLiabilityRightOfUseAsset
|
184000 | usd |
| CY2021Q4 | sls |
Deferred Tax Liability Right Of Use Asset
DeferredTaxLiabilityRightOfUseAsset
|
152000 | usd |
| CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
184000 | usd |
| CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
152000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
184000 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
152000 | usd |
| CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
184000 | usd |
| CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
152000 | usd |
| CY2022Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 | usd |
| CY2021Q4 | us-gaap |
Deferred Tax Liabilities
DeferredTaxLiabilities
|
0 | usd |
| CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.210 | |
| CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.001 | |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.002 | |
| CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.119 | |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
-0.140 | |
| CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.087 | |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.058 | |
| CY2022 | sls |
Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
|
-0.002 | |
| CY2021 | sls |
Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
|
-0.002 | |
| CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.003 | |
| CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.001 | |
| CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.011 | |
| CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
| CY2022 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
3600000 | usd |
| CY2022 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
129000 | usd |
| CY2021 | us-gaap |
Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
|
75000 | usd |
